enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers

This study explores the feasibility, acceptability, and preliminary efficacy of a social support intervention in cancer caregivers who live in rural communities. Cancer caregivers need support, especially when they live at a distance from healthcare centers. enCompass Carolina is a social support intervention, that supports caregivers by helping them find and use new sources of support. The purpose of this study is to test and receive feedback about the program.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

Inclusion criteria for caregivers In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

  1. English-speaking.
  2. Ability to provide written or electronic informed consent to participate in the study.
  3. Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
  4. Age ≥ 18 years at the time of consent. Identify as an informal (unpaid) caregiver for a rural-dwelling adult with a stage II-IV solid tumor or any hematologic malignancy in active treatment (see eligibility criteria for patients).

Inclusion criteria for subjects with cancer In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

  1. Their identified caregiver is enrolled in the study
  2. English-speaking.
  3. Ability to provide written or electronic informed consent to participate in the study.
  4. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
  5. Age ≥ 18 years at the time of consent. Have a diagnosis of stage II-IV solid tumor or any hematologic malignancy receiving active treatment s, not including hormonal therapy

7. Live in a rural area according to the USDA's Rural/Urban Commuting Area (RUCA) score of >4.

Exclusion Criteria

Exclusion criteria for caregivers

  1. Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
  2. Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
  3. Participation in the intervention development phase of this intervention.

Exclusion criteria for subjects with cancer

  1. Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
  2. Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
  3. Their caregiver does not enroll in the study or withdraws consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Caregiver of subject with cancer
Adults who identify as a primary unpaid caregiver for a rural-dwelling adult with cancer.
The web application allows caregivers to visually identify and organize their existing social network (family, friends, community of worship, and others) to assist with their support needs, tailored to their context. For each of the six support social support domains (in-home, informational, communication, financial, emotional and spiritual, transportation (e.g., emotional, informational, practical), the enCompass web application prompts the individual to identify members of their network. After completing each domain, caregivers are presented with a visual social support
Caregivers engage in up to 8 manualized, telephone/videoconference visits with a trained caregiver coach. The caregiver coach uses the study manual and interview guide to provide support for caregiver support-seeking and problem-solving.
No Intervention: Subject with Cancer
Subjects is with cancer and receive care from caregivers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study feasibility - caregiver enrollment
Time Frame: 8 weeks
Study feasibility will be measured by caregiver enrollment rates, defined as the proportion of eligible caregivers approached about the study who consent to participate.
8 weeks
Study feasibility - Caregiver intervention engagement
Time Frame: 8 weeks
Study feasibility will be measured by caregiver intervention engagement, defined as the proportion of enrolled caregiver subjects who receive at least one intervention visit.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention acceptability-qualitative
Time Frame: 4 weeks, 8 weeks

Intervention acceptability will be measured using the Acceptability of the Intervention Measure (AIM) survey scores.

AIM is a survey questionnaire that includes 4 questions. Response Scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Scoring Instructions: Scales can be created for each measure by averaging responses. Scale values range from 1 to 5. No items need to be reverse-coded.

4 weeks, 8 weeks
Intervention acceptability-quantitative
Time Frame: 4 weeks, 8 weeks
Intervention acceptability will be evaluated using thematic analysis of post-intervention semi-structured interviews.
4 weeks, 8 weeks
Caregiver self-efficacy
Time Frame: Baseline, 4 weeks, 8 weeks

Caregiver self-efficacy will be measured using the Coping Self-Efficacy Scale (CSES).

The CSES is a 26-item measure of one's confidence in performing coping behaviour when facing life challenges. It measures the use of problem-focused coping, receiving of social support and stopping unpleasant emotions and thoughts. Scores range from not at all confident=0 to very confident=100. A score of 0 means 'extremely low self efficacy' and a score of 100 means 'extremely high self efficacy'.

Baseline, 4 weeks, 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Erin E Kent, PhD, MS, Department of Health Policy and Management Gillings School of Global Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2023

Primary Completion (Anticipated)

July 1, 2025

Study Completion (Anticipated)

July 1, 2025

Study Registration Dates

First Submitted

April 12, 2023

First Submitted That Met QC Criteria

April 12, 2023

First Posted (Actual)

April 25, 2023

Study Record Updates

Last Update Posted (Actual)

May 24, 2023

Last Update Submitted That Met QC Criteria

May 23, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • LCCC2242

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Eco-mapping tool

3
Subscribe